Menu
ncarol.com
  • Home
  • Music
  • Asheville Music
  • Entertainment
  • Real Estate
  • Business
  • Technology
  • Health
  • Books
ncarol.com

Lenoir NC Company Files US Patent Application for "Voice-Activated Talk-Through Safety Mask Appliance and Method" dubbed, "VATTSMA™"
ncarol.com/10061312

Trending...
  • New Finnish Affiliate Site Ilmaiskierrokset.com Puts Wager-Free Spins in the Spotlight
  • Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
  • RAS AP Consulting Advances 1099 Education and Readiness Initiative Through IFOL Training and Finance Technology Showcase
Inventors find 'Silver Lining in COVID-19 Cloud' with New Talk-Through Face Mask, Miniature Loudspeaker and Telecommunications Emitter Developed at University of Pittsburgh

KITTY HAWK, N.C. - ncarol.com -- Joyce Mann, Chairman and CEO of Lenoir-based RMANNCO, Inc., announced today that RMANNCO, Inc. has caused the formal filing of Letters Patent Application drawn to a new means and method of communication and biocontrol protection while wearing any kind of face covering, such as surgical masks, plastic face shields or cloth face.  The title of the invention is "Voice-Activated Talk-Through Safety Mask Appliance and Method", called, 'VATTSMA'™. See: https://doctorjoesoriginal.weebly.com/  The Inventors listed on the patent application are Ms. Joyce M. Mann and Dr. Joseph A. Resnick.

The new product has its foundations in three early patents issued by inventor, Resnick, while a student at the University of Pittsburgh Eye and Ear Hospital, Pittsburgh, PA where he developed 'The Resnick Tone Emitter', known as the 'Talking-Tooth', which issued as US Patent #4,571,739, Intraoral Electrolarynx; US Patent #4,706,292, Speech Prosthesis; and US Patent #5,015,179 Speech Monitor. See: https://tinyurl.com/y742blc7 . Dr. Joe Resnick, a former NASA Scholar and Research Scientist, said, "Parts of those prior technologies are used in the new VATTSMA™ product for which letters patent protection is pending approval.  Of particular value and use for the new product is the miniature loudspeaker and electronics 'chip' we developed at Pitt in the 1980's, as these are 'fluid-resistant' and won't be affected by moisture from breathing, talking, etc.  A value-added feature is that the electronics package is removable allowing its use on new masks once original masks have become soiled or unwanted".  Resnick continued, "As an 'Optimist', I like to find good outcomes in everything…even worst-case scenarios such as the COVID-19 Pandemic. I have always been aware of the problems communicating while wearing a surgical-type mask.  This was problematic when I was a student at Pitt, nearly 40 years ago…and has remained problematic to this day…even in my own work in my own laboratory.  Enter the new VATTSMA™ technology.  Now, people wearing masks equipped with the amplification emitter who work in health care, in hospitals, etc., or government officials giving speeches or having to talk in public, will be able to do so without removing the mask and their speech will be more intelligible, more audible at 83 dB, which is just a little louder than speech during normal communication. So, to quote the old sayings, 'Every cloud has a silver lining'.  And the VATTSMA™ technology represents a little piece of 'silver lining' that we have realized necessary and which fills a real-world need, despite this horrible Pandemic. 'Fortune favors the Bold'".

More on ncarol.com
  • New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
  • Genuine Hospitality, LLC Selected to Operate Holiday Inn Express & Suites Jacksonville – Town Center
  • Shiokly Launches Online Marketplace to Help Singapore Home-Based Businesses Sell More, With First Product Listed Free
  • Freight Broker 911 and Milton Collier Introduce "What's The 911?"—A New Podcast Built on Real Talk, Real Freight, and Real Opportunity
  • PropAccount.com Launches PropWallet, Turning Prop Firm Payouts Into Repeat Sales

Since the declaration of the COVID-19 Pandemic by the World Health Organization in March 2020, most of the world's population has resorted to, or been mandated to, wearing some form of mask or face covering thought to help slow/stop the spread of the Corona Virus, COVID-19.  According to the US Department of Commerce more than 2 Billion safety masks have been produced and used since the outbreak of the Corona Virus in January 2020. The US Department of Commerce reports that more than 300 Million N-95 masks have been ordered by various US government agencies since March 2020 with the US Military ordering millions more.

Mann said that the initial price for the individual VATTSMA™ unit will be around $20.00, and that a test-market study is being orchestrated on the 'GoFundMe' Crowdfunding platform at https://tinyurl.com/yau4duub .  Mann said, "That price should drop, significantly, as large orders are received and the units can be contracted and sold at retail by the tens-of-thousands".  Mann said, "Yes, they may seem a bit pricey, at first.  But the retail price will fall, a function of supply and demand economics.  As we receive more and more orders and these are passed along to our manufacturers, the electronics component price will fall, drastically.  When that happens we will be able to offer the technology/masks for about the same retail price as an N-95 mask today".

Mann said that RMANNCO, Inc., Licensee to the technology, is actively seeking JV partners to assist with global marketing of the VATTSMA™ product line because the potential market size is so large.

More on ncarol.com
  • Tonight in Asheville: KayeDinero Drops "Underground" and Opens Beat Catalog
  • KOLBUS America, For All Of Your Hycorr Equipment And Service Needs
  • Heritage at Hopewell Announces New 3.875% Year-One Mortgage Rate Buydown Incentive on Quick Delivery Townhomes (7.11% APR)
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • Prince's Collaborator Shelby J To Be A Special Guest For "a Deadly Proposal" Red Carpet

END

For Additional Information Contact:

Ms. Joy Mann, Chief Executive Officer
Email: Joy@rmannco.com
Phone: 478-244-2131
www.rmannco.com

Contact
RMANNCO, Inc.
Joyce M. Mann, CEO
nxgenusa@aol.com
8285727705


Source: RMANNCO, Inc.

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Nautical Advisory Shares Buyer Perspective in Forbes Agency Council Webinar for Agency Founders
  • AdLeverage Brings Golf Simulator Contest and Home Services Marketing Expertise to Service World Expo 2026
  • Cleveland Factory Worker Seeks Funding for AI-Readable Archive Exploring Advanced AI Restraint and Human Survival
  • TradeJARnal Launches Innovative Trading Journal to Help Stock and Options Traders Build Discipline and Smarter Trading Habits
  • Pursant Founder Mark Herbick Joins STS Capital Partners as CEO
  • Tampa Holiday Sessions: Captured by Mallary Opens 2026 Christmas Minis With Two New Sets
  • Tampa Web Design Launches New Website for Entrepreneur and Capital Markets Advisor Martin Sumichrast
  • Miami Dade College and World Affairs Council of Miami announce Navarro-Cabrera scholarship
  • Nious Media Releases Debbie Bishop Interview on AI, Creativity, and Entertainment
  • RPP to host first Professional Padel Week in Miami and announce the 2026 USA Awards winners
  • UK Financial Ltd. Announces Maya Preferred PRA as First Fully Verified Asset on MAYA CHAIN; Chainlink Proof of Reserve Integration Planned for Network
  • ALight Technology And Services Limited Advances Through Peachscore + Dealum Accelerator and Join LvlUp Labs
  • International Misophonia Foundation Launches Sensory Accessible Technology Initiative to Address Overlooked Digital Accessibility Barriers
  • RAS AP Consulting Advances 1099 Education and Readiness Initiative Through IFOL Training and Finance Technology Showcase
  • Heritage at Manalapan Announces New 3.875% First-Year Mortgage Rate Buydown (7.11 APR)
  • AthleteMerch.com Surpasses 100,000 Custom Items Delivered to Fans Nationwide
  • Steve Weclew is Appointed by STS Capital Partners as Managing Director
  • New Finnish Affiliate Site Ilmaiskierrokset.com Puts Wager-Free Spins in the Spotlight
  • Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
  • Immerse Yourself in the Historic Tochigi Autumn Festival, Celebrated Every Two Years Since 1874
_catLbl0 _catLbl1

Popular on ncarol.com

  • Constantine "Costa" Kapothanasis II Acquires The Lubri-Loy Company, Carrying a 77-Year-Old American Lubricant Brand Into Its Next Era - 220
  • Parade of Homes Winners Announced - 200
  • LowSignalMail Lets Users Handle Gmail by Text Message - 196
  • North Carolina Author Carrie Sybert Celebrates Three Published Books - 167
  • Nious Media Expands Independent Entertainment Network Through Gaming, Music and Digital Storytelling - 156
  • RAS AP Consulting Issues National Compliance Alert and Launches Q4 2026 AP Readiness Program Ahead of IRS FIRE → IRIS Cutover - 145
  • Pregis Launches Sharp InfinX: On-Demand Rightsized Mailing System Delivering a Precision-Sized Mailer for Every Order - 141
  • Thunderbird F-16 Arrives 11/11 - 136
  • LCM Company Explains Professional Upholstery Cleaning in Charlotte, NC - 134
  • B Street Productions Announces Red Carpet Premiere Of Thriller "a Deadly Proposal" In North Car - 117

Similar on ncarol.com

  • New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX)
  • Longevity Academy Features Gail Humble, MD of KLOTHO SKIN in the Longevity Leaders Project
  • Expanding Into Medically Supervised Wellness With Major Apollo Wellness Centers Announcement; Sibannac, Inc. (Stock Symbol: SNNC)
  • Preston Dermatology & Skin Surgery Center and Dr. Sheel Desai Solomon Win Gold in Raleigh's Best Awards for Second Consecutive Year
  • Mr Hospital Bed Cites Hill Rom Hospital Bed Models Best Value Home Care Hospital Beds 2026
  • Hospital Direct Medical Equipment Company Seeing Growth in Used Refurbished Medical Equipment Sales
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute